Company · Ownership research

TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA

CIK 0000818686

Form 4 transactions dated Oct 1, 2023 to Oct 15, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

This page lists 30 of 35 rows; the complete set is available through the API.

Insider filings on file run through Sep 22, 2026.

Insider purchases & sales

Purchased: $20.99K
Sold: $160.72M

Oct 1, 2023 – Sep 22, 2026
Available records · partial months are marked ·

Insiders in this window

202510 of 30 preview events · 35 available in 2025

Date	Insider	Activity	Trade value (USD)	% of prior holding
Dec 16, 2025	Weiss Amir Chief Accounting Officer	Sale	$371.50K 12,300 shares sold	68.52% sold Direct holding	▾
Dec 16, 2025	MIGNONE ROBERTO Director	Sale	$2.34M 77,400 shares sold	17.39% sold Indirect holding	▾
Dec 9, 2025	Daniell Richard Exec. VP, European Commercial	Sale	$3.31M 115,468 shares sold	70.47% sold Direct holding	▾
Dec 9, 2025	Sabag Mark See "Remarks"	Sale	$6.23M 216,892 shares sold	80.41% sold Direct holding	▾
Nov 26, 2025	MIGNONE ROBERTO Director	Sale	$1.30M 50,000 shares sold	10.10% sold Indirect holding	▾
Nov 20, 2025	Fox Christine EVP, Head of U.S. Commercial	Sale10b5-1 footnote	$699.52K 28,229 shares sold	30.73% sold Direct holding	▾
Nov 14, 2025	Fox Christine EVP, Head of U.S. Commercial	Sale	$753.32K 30,000 shares sold	51.38% sold Direct holding	▾
Nov 6, 2025	MIGNONE ROBERTO Director	Sale	$4.82M 200,000 shares sold	28.78% sold Indirect holding	▾
Nov 6, 2025	Weiss Amir Chief Accounting Officer	Sale	$300.56K 12,300 shares sold	40.66% sold Direct holding	▾
Sep 5, 2025	McAvoy David R. EVP, Chief Legal Officer	Purchase	$20.99K 1,113 shares bought	9.34% added Direct holding	▾

Showing 30 / 35 record groups in 2025. The complete set is available through the API.

TEVA PHARMACEUTICAL INDUSTRIES LTD · TEVA

Follow the people behind the trades.

Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 30 of 35 purchase / sale groups and 30 of 107 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

list_insider_transactions
{"ticker":"TEVA","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Share totals are on today's split-adjusted basis. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.